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Abstract
AIM: To analyze the metastasis-related proteins in 
hepatocellular carcinoma (HCC) and discover the biomark-
er candidates for diagnosis and therapeutic intervention 
of HCC metastasis with bioinformatics tools.
METHODS: Metastasis-related proteins were determined 
by stable isotope labeling and MS analysis and analyzed 
with bioinformatics resources, including Phobius, Kyoto 
encyclopedia of genes and genomes (KEGG), online 
mendelian inheritance in man (OMIM) and human protein 
reference database (HPRD).
RESULTS: All the metastasis-related proteins were linked 
to 83 pathways in KEGG, including MAPK and p53 signal 
pathways. Protein-protein interaction network showed 
that all the metastasis-related proteins were categorized 
into 19 function groups, including cell cycle, apoptosis and 
signal transduction. OMIM analysis linked these proteins 
to 186 OMIM entries.
CONCLUSION: Metastasis-related proteins provide HCC 
cells with biological advantages in cell proliferation, 
migration and angiogenesis, and facilitate metastasis of 
HCC cells. The bird’s eye view can reveal a global charac-
teristic of metastasis-related proteins and many differen-
tially expressed proteins can be identified as candidates 
for diagnosis and treatment of HCC.
© 2008 The WJG Press. All rights reserved.
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INTRODUCTION
Hepatocellular carcinoma (HCC) is one of  the most 
common cancers in the world with 626 000 new cases 
occurred in 2002[1]. Surgical resection remains the prima-
ry treatment of  choice, but because of  the very high rate 
of  metastasis and poor prognosis, the number of  deaths 
is almost the same of  new cases (598 000) occurred each 
year worldwide. Metastasis is a highly complicated bio-
logical process involving multiple proteins functioning in 
a coordinated manner and the molecular mechanism un-
derlying the metastasis of  HCC is not completely under-
stood. Investigations on metastasis-related proteins and 
the molecular mechanism are urgent in the campaign 
against HCC both in the world and in China[2]. Technol-
ogy advances in genomics and proteomics would fa-
cilitate our understanding of  HCC metastasis. Genome 
analysis with DNA array can be used to scan different 
gene expressions in different HCC samples and valuable 
biomarkers have been discovered[3]. However, no well 
linear correlation has been found between gene and pro-
tein expression levels due to splice process of  mRNA 
and post-transcriptional regulation[4,5]. Hence, differential 
expression profile analysis of  a large number of  proteins 
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is an essential step in understanding the mechanism of  
metastasis and in discovering the diagnostic markers and 
therapeutic targets for HCC.
Quantitative proteomics using stable isotope labeling 
has the necessary ability to rapidly identify and quantify 
differentially expressed proteins in two or more samples 
with a high throughout, and thus is currently used as the 
workhorse for discovering and validating proteins related 
with a special disease in clinical research. In our previ-
ous work, the proteome profiles of  two HCC cell lines 
with different metastasis potentials were compared using 
stable isotope labeling and 223 differentially expressed 
proteins were identified confidently. In this study, we 
analyzed these proteins with bioinformatics tools to 
discover their biological role in the process of  metas-
tasis. Our results show that bioinformatics analysis can 
provide a valuable molecular basis for systematic inter-
pretation of  the mechanism underlying HCC metastasis 
where potential protein markers could be characterized.
MATERIALS AND METHODS
Chemicals and reagents
[5,5,5-d3] leucine (leu-d3) was purchased from Cambridge 
Isotope (Andover, MA). Formic acid (FA) and trifluo-
roacetic acid (TFA) were from FlukA (Switzerland) and 
acetonitrile (ACN) was from Merk (Darmastadt, Germany). 
Trypsins were purchased form Promega (Madison, WI). 
Dulbecco’s modified Eagle’s medium (DMEM) and 
dialyzed fetal bovine serum (FBS) were from Gibco-
Invitrogen (Grand Island, NY, USA), and normal FBS 
was from PAA Laboratories GmbH. All others compo-
nents of  cell culture medium, amino acid kits, inorganic 
salts, vitamin solution, etc, were obtained from Sigma (St, 
Louis, MO). Other chemicals for SDS-PAGE gel elec-
trophoresis, peptide extraction, and sample preparation 
for LC-ESI-MS were purchased from Sigma (St. Louis, 
MO, USA).
Cell culture, sample preparation 
HCC cell line MHCC97H with a high metastasis poten-
tial was cultured in a normal DMEM, while MHCC97L 
with a low metastasis potential was cultured in a special 
DMEM, in which leu-d3 was supplemented to substi-
tute its unlabeled counterpart depleted in the normal 
DMEM[6]. Cells were harvested at the 80% confluence 
and treated with a lysis buffer containing 20 mmol/L 
Tris-HCl (pH 7.4), 150 mmol/L NaCl, 3 mmol/L MgCl2, 
1 mmol/L CaCl2, 10 mL/L NP-40, and 1 mmol/L PMSF. 
Samples were centrifuged at 10 000 r/min for 30 min 
at 4℃ and stored at -80℃ for electrophoresis. Samples 
from MHCC97H and MHCC97L were mixed at 1:1 of  
total protein mass and separated on SDS-PAGE. Tryp-
sin digestion and peptide extraction were carried out as 
previously described[6].
LC separation and MS analysis
Peptides were resuspended in 5 μL of  1 mL/L TFA so-
lution and directly loaded onto a 300 μm × 100 mm C18 
column (Grace Vydac, Hesperia, CA) using an Agilent 
1100 binary pump. The following gradients were used for 
peptide separation: 50-400 ml/L B from 0 min to 50 min, 
400-800 ml/L B from 50 min to 70 min, 800-950 ml/L 
B from 70 min to 90 min, where solvent A was 1 mL/L 
FA and solvent B was 1 mL/L FA in ACN. Fractions 
were collected and deposited on a 12 × 16 array Ap-
plied Biosystems plate. Alpha-cyano-4-hydroxycinnamic 
acid (CHCA) was used as a matrix. Both MALDI-MS 
and MS/MS mass spectra were obtained with the Ap-
plied Biosystems 4700 proteomics analyzer (Framing-
ham, MA, USA). MS/MS data were searched from the 
international protein index (IPI, version 3.07) human da-
tabase with Mascot (version 1.9, Matrix Science, Boston, 
MA). Leu-d3 modification was added into a modification 
file. Error tolerance of  peptide MS was set at 0.3 U, MS/
MS tolerance at 0.6 U. One missed cleavage per peptide 
was allowed.
Bioinformatics analysis of metastasis-related proteins
UniProt (Swiss-Prot) format file (ipi.HUMAN.dat) of  
IPI entries and cross-reference file were downloaded 
from IPI database (human, version 3.07, ftp://ftp.ebi.
ac.uk/pub/databases/IPI/). GeneID, gene symbol and 
Swiss-Prot accession number for each metastasis-related 
protein were retried from the cross-reference file. Amino 
acid sequences of  IPI entries in ipi.HUMAN.dat were 
used in prediction of  transmembrane segments with 
Phobius (http://www.ebi.ac.uk/Tools/phobius/)[7].
Protein-protein interactions were extracted from 
human protein reference Database (HPRD)[8] and 
interaction network was demonstrated with Osprey 
(version 1.2.0, http://biodata.mshri.on.ca/osprey/
index.html)[9]. GeneIDs were mapped to the KEGG 
pathway with a Perl script through the API service at 
the KEGG (http://www.genome.jp/kegg/soap/doc/
keggapi_manual.html)[10].
Cross-references to each entry in the online 
mendelian inheritance in man (OMIM) database were 
obtained from the UniProtKB/Swiss-Prot subset of  IPI 
entries through a Perl script. The detailed descriptions 
of  OMIM entries were obtained from the OMIM web 
site (http://www.ncbi.nlm.nih.gov/omim).
Perl scripts were written in the environment of  Ac-
tivePerl (version 5.8.8, http://www.activeperl.com).
RESULTS
Quantification of differentially expressed proteins between 
MHCC97H and MHCC97L
HCC cell l ines MHCC97H and MHCC97L were 
subcloned from the same cell line MHCC97, with a high 
and low metastasis potential, respectively[11]. MHCC97L 
was cultured in a special medium for 10 passages and 
thus labeled completely with leu-d3 while MHCC97H 
was cultured in a normal medium. Samples from normal 
(MHCC97H) and leu-d3-labeled (MHCC97L) cells were 
combined and analyzed with off-line LC-MALDI-MS. 
Changes in expression of  506 proteins were quantified 
as previously described[12]. A high confidence as a 
single or multiple leucine-containing tryptic peptides 
was detected for each of  these proteins. Peptide 
AFVTPSVLR from Pr-domain zinc finger protein 5 
(IPI00032997) contained one leucine, and the expression 
ratio was quantified as 2.01:1 (MHCC97H: MHCC97L) 
by comparing the intensity of  peaks 989.6 and 992.6 
(Figure 1). The results will be reported in another article 
in details and some important proteins are listed in Table 
1. A total of  223 proteins with an expression ratio > 1.5 
or < 0.67 were defined as metastasis-related proteins and 
further analyzed with bioinformatics tools.
The use of  2DE-MS for profiling the membrane 
proteins is limited due to the relative insolubility of  
these proteins under conditions suitable for 2-DE 
analysis[13,14]. However, membrane proteins are likely to 
be very import in understanding metastasis. For this 
reason, we undertook SDS-PAGE to identify more 
membrane proteins in our study. Phobius is a web tool 
to predict transmembrane topology of  protein with 
a hidden Markov model[7]. Therefore, it was used to 
predict the transmembrane segments of  metastasis-
related proteins in our study. Several membrane proteins 
with multi-transmembrane segments were identified, 
such as sodium channel protein type 1 subunit alpha 
(IPI00216029) containing 24 transmembrane segments, 
brain calcium channel Ⅰ (IPI00217499) containing 
23 segments, HH1 (IPI00377006) containing 22 
segments, hNaN (IPI00513973) containing 20 segments. 
It was difficult to detect these proteins with multi-
transmembrane segments using the 2DE method due 
to their low solubility in 2DE lysis buffer. In our study, 
more membrane proteins were detected than in a 
previous report using 2DE[15]. The dataset of  metastasis-
related proteins here provided comprehensive biology 
information on the molecular mechanism of  HCC 
and would facilitate the discovery of  biomarkers for its 
diagnosis and therapy.
Biological pathways
Based on the API service of  KEGG (http://www.
genome.jp/kegg/soap/doc/keggapi_manual.html)[10], 
a Perl script was used to associate these metastasis-
related proteins with known pathways and disease states 
(Table 2). All the proteins were linked to 83 biological 
pathways and human diseases in the KEGG, including 
antigen processing and presentation, regulation of  
actin cytoskeleton and signal pathways. Among these 
pathways, many biological processes were connected 
with metastasis in previous studies, including MAPK, 
p53 and ErbB, which are involved in regulating cell 
proliferation, angiogenesis and migration. In addition, 
several metastasis-related proteins were suggested to 
be involved in other types of  cancer. For example, 
PAK7 and PAK 4 functioned in regulation of  renal cell 
carcinoma according to the annotations in the KEGG.
Protein-protein interaction network
With the software Osprey and the protein-protein in-
teraction data from HPRD, protein-protein interaction 
network of  metastasis-related proteins was visualized 
(Figure 2, Table 3). The network contained 871 proteins 
(nodes) and 892 interactions (edges), and the edge/node 
was 1.02. Osprey also provides a functional tool to clus-
ter proteins by their GO process, and proteins sharing 
the same GO process were grouped together. Based on 
the GO annotations in Osprey, all the proteins in the 
network were classed into 19 known biology function 
groups. For example, 120 proteins were involved in sig-
Protein name  IPI number     Ratio1 NO2 Coverage (%)3 Category
Filamin C IPI00178352 2.49 ± 0.15   2         1.28 Cytoskeleton 
Obscurin IPI00549822 2.91 ± 0.18   2         1.16 Cytoskeleton 
Keratin 8 IPI00554648 0.56 ± 0.15   4       25.1 Cytoskeleton
Titin IPI00179357 1.73 ± 0.12   5         1.11 Cytoskeleton
Plectin 7 IPI00398776 2.49 ± 0.13   2         1.19 Cytoskeleton
MTA2 IPI00171798 0.24 ± 0.11   2         2.69 p53 regulation
Low density lipoprotein 
receptor-related protein 
1 (LRP1)
IPI00020557 0.58 ± 0.15   2         2.27 Cell migration, 
proliferation, 
angiogenesis
Mos IPI00018290 2.86 ± 0.2   2         6.36 Mitoses
Table 1  Metastasis-related proteins in HCC
1Ratio calculated as MHCC97H/MHCC97L, 2number of quantified peptides, 3protein coverage calculated as the 
number of amino acid residues for protein identification divided by the total number of amino acid residues of 
the protein.
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Figure 1  MS spectra of peptide AFVTPSVLR of Pr-domain zinc finger 
protein 5 (IPI00032997) and its labeled form AFVTPSVd3LR. Quantification 
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nal transduction, 57 in DNA repair, and 6 in cell cycle 
(Table 3). This network could facilitate us to pinpoint 
the key proteins that play an important role in HCC me-
tastasis and also help us to identify potential markers for 
the diagnosis and treatment of  HCC.
Disease association
OMIM is one of  the most comprehensive resources of  
human genes and genetic disorders to support research 
in human genomics and proteomics[16]. A total of  145 
proteins were linked to 186 OMIM entries, of  which 
141 described disease genes and 45 disease pheno-
types. Among the disease phenotypes, one was cirrhosis 
(OMIM #215600) which would afford the development 
of  HCC.
DISCUSSION
The accuracy of  comparative proteomics using stable 
isotope labeling can be affected by various factors, such 
as isotope distribution[17]. When the peptide contains one 
leucine, M+ ion peak of  labeled peptide overlaps with 
the isotope distribution of  the corresponding normal 
peptide. In order to eliminate the effect of  isotope dis-
tribution and ensure the accuracy of  quantification, the 
theoretical intensity of  (M+3)+ peak of  normal peptide 
is subtracted from the labeled peak by calculating its 
isotope distribution[12]. Peaks with a signal-to-noise ratio 
< 30 are also excluded in quantification to attenuate the 
effect of  noise on quantification. These modifications 
ensure the reliability of  quantification with stable isotope 
labeling.
It was reported that some differentially expressed 
proteins function in the process of  metastasis and 
plectin has an essential role in cell migration through 
MAP kinase signaling cascades[18,19]. Filamin C can orga-
nize actin polymerization and its dysregulation has been 
observed in some cancer samples[20]. Obscurin binding 
to titin and sarcomeric myosin[21,22] plays a role in the 
regular alignment of  network sarcoplasmic reticulum 
developing sarcomeres[23]. The gene encoding this pro-
tein is interrupted by the translocation in Wilms’ tumor 
and functions as a tumor suppressor[24]. Another study 
showed that obscurin is involved in gastrointestinal 
stromal tumor and leiomyosarcomas[25]. Proto-oncogene 
serine/threonine-protein kinase Mos acts as an up-
Cell function Interactors Percent (%)
Cell cycle          6       0.69
DNA repair        57       6.54
Stress response        14       1.61
Protein biosynthesis          9       1.03
Carbohydrate metabolism        26       2.99
DNA replication          3       0.34
Transcription        39       4.48
RNA processing        14       1.61
RNA localization          1       0.11
Signal transduction      120     13.78
Transport        41       4.71
Protein dephosphorylation          9       1.03
Cell organization and biogenesis      124     14.24
Metabolism        70       8.04
DNA damage response          3       0.34
Protein transport        59       6.77
Protein phosphorylation        60       6.89
Protein degradation        37       4.25
DNA repair        13       1.49
Unknown      166     19.06
Table 3  Function classification of protein-protein interaction 
network




IPI00025252 Protein disulfide-isomerase A3 precusor
IPI00037070 Splice isoform 2 of heat shock cognate 71 kDa protein
IPI00144014 MHC Cass I antigen
IPI00514377 Heat shock 70 kDa protein
Regulation of actin 
cytoskeleton




Renal cell carcinoma IPI00001814 PAK 7
IPI00384231 PAK4 protein
Thyroid cancer IPI00022970 Translocated promoter region
Small cell lung cancer IPI00217461 Splice isoform 3 of apoptotic protease activating factor 1
IPI00377045 Laminin alpha 3 splice variant B1
Prostate cancer IPI00219757 Glutahione S-transferase protein
p53 pathway IPI00006160 Splice isoform alpha of tumor protein P73
IPI00217461 Splice isoform 3 of apoptotic protease activating factor 1
MAPK pathway IPI00018290 Mos
IPI00037070 Splice isoform 2 of heat shock cognate 71 kDa protein (HSP70)
IPI00155892 Voltage-dependent calcium channel gamma-5 subunit isoform B
IPI00178352 Splice isoform 1 of filamin C
IPI00382696 Splice isoform 1 of filamin B
IPI00514377 Heat shock 70 kDa protein 1A
ErbB pathway IPI00001814 PAK 7
IPI00384231 PAK4 
Table 2  KEGG pathway analysis of metastasis-related proteins

































































































Figure 2  Protein-protein interaction network. 
A: Interactions of metastasis-related proteins. 
Based on the data from HPRD, protein-protein 
interactions were plotted using Osprey. Interactors 
are represented as nodes and grouped according to 
their biologic function based on Osprey annotation; 
B: A subnetwork displaying important proteins, such 
as Mos, LRP1, MTA2, and MAPK.
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stream activator of  the MEK/MAPK/p90Rsk pathway 
regulating M-phase and G2 arrest[26,27]. LRP1 can medi-
ate growth inhibition by IGFBP-3 and cell migration 
inhibition by binding to apoE[28]. LRP1-mediated clear-
ance of  uPA is one of  the mechanisms involved in the 
control of  human thyroid carcinoma cell invasion[29]. It 
was reported that up-regulation of  matrix metallopro-
teinase-9 by tPA in cell culture and in vivo is mediated by 
LRP1[30]. LRP1 also plays a role in determining the blood 
vessel structure and angiogenesis[31].
Two biological pathways discovered by KEGG 
analysis in our study were dysregulated and connected 
with HCC metastasis. The tumor suppressor protein 
p53 plays a pivotal role in the regulation of  apoptosis 
and cell cycle arrest. In our study, two p53 regulators, 
p73 and apoptotic protease activating factor 1, were dif-
ferentially expressed. MTA2 is a p53-interacting protein 
that induces p53 deacetylation[32,33]. Dysregulation of  
p53 function is linked with an unfavorable prognosis 
of  a large number of  more aggressive tumor types[34]. 
Eukaryotic cells possessing multiple MAPK pathways 
coordinately regulate diverse cellular activities including 
motility, survival, apoptosis and differentiation[35,36]. The 
Mos/MAPK/p90Rsk pathway regulates cell cycle pro-
gression in oocytes[37], whereas ectopic Mos expression 
in the early cleavage embryo induces M phase arrest[27]. 
HSP70 exhibits regulatory functions of  c-Jun, ERK and 
the JNK pathway, thus inhibiting cell apoptosis[38]. The 
MAPK signaling pathway has long been identified as a 
convergence point for normal and pathologic signaling 
inputs, rendering it an appealing target for therapeutic 
intervention[39]. Various treatment modalities targeting 
p53 and MAPK pathway are currently under investiga-
tion, and dysregulation of  p53 and MAPK pathway in 
HCC metastasis would facilitate finding targets for HCC 
therapy[39-41].
In conclusion, metastasis-related proteins are dys-
regulated in HCC metastasis. Biochemical alterations in 
cell proliferation and migration, angiogenesis and im-
mune response confer selective biological advantages to 
HCC cells in the process of  metastasis. Bioinformatics 
analysis of  metastasis- related proteins provides valuable 
biological information on the molecular mechanism of  
metastasis and potential therapeutic targets for HCC. 
 COMMENTS
Background
Hepatocellular carcinoma (HCC) is one of the most common cancers in the 
world with a high death rate. Metastasis is the major cause of HCC-related 
death. Discovering metastasis-related proteins would facilitate the diagnosis 
and treatment of HCC. Quantitative proteomics with stable isotope labeling is a 
powerful tool to analyze proteome differences between samples with different 
metastasis and to discover potential therapeutic targets for HCC.
Research frontiers
Our study showed the differential proteome profiles of two HCC cell lines with 
metastasis using stable isotope labeling. Based on the functional annotations 
with bioinformatics tools, metastasis-related proteins were functionally an-
notated with Kyoto encyclopedia of genes and genomes (KEGG) pathway, 
protein-protein interactions from human protein reference database (HPRD) 
and diseases from online mendelian inheritance in man (OMIM). Functional an-
notations showed that many proteins in the profile were clearly connected with 
the process of tumor metastasis.
Innovations and breakthrough
To the best of our knowledge, the present study showed the largest differential 
proteome profile of HCC metastasis. Functional annotations with bioinformatics 
tools showed that metastasis-related proteins were linked with 82 KEGG path-
ways, 892 interactions and 186 disease entries in OMIM, suggesting that they 
play a possible role in metastasis of HCC.
Applications
The differential proteome profile gives more valuable information on the mo-
lecular mechanism of metastasis of HCC and provides potential biomarkers for 
the diagnosis and treatment ofr HCC.
Peer review
This is a well conducted study. The manuscript describes the differential pro-
teome profile that gives more information on the molecular mechanism of me-
tastasis of HCC. The study also invested certain potential biomarkers that can 
be used in the diagnosis and treatment of HCC.
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